Close Menu

ductal carcinoma in situ

Cancer Moonshot-funded teams are profiling pre-cancers in an effort to establish targeted treatment, detection, and prevention methods that can be applied before cancers form.

The company will now be able to market the test, which algorithmically weighs molecular markers and clinical information, in all 50 US states.